Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients

Transplantation Proceedings

Volumn 37, Issue 6, 2005, Pages 2632-2633

  Iaria, G ^a   Urbani, L ^a   Catalano, G ^a   De Simone, P ^a   Carrai, P ^a   Petruccelli, S ^a   Morelli, L ^a   Coletti, L ^a   Garcia, C ^a   Liermann, R ^a   Mosca, F ^a   Filipponi, F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; LUTEINIZING HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROLACTIN; STEROID; TACROLIMUS; TESTOSTERONE;

ADULT; CASE REPORT; CONFERENCE PAPER; GYNECOMASTIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RECIPIENT; TESTOSTERONE BLOOD LEVEL;

EID: 25144466621     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.06.019     Document Type: Article

References (5)

1. M. Kodama, T. Kodama, M. Murakami Cyclosporin A is a hormonal immunomodulator. I. Human study In Vivo 6 1992 167
2. A.D. Baildam, R.M. Higgins, E. Hurley Ciclosporin A and multiple fibroadenomas of the breast Br J Surg 83 1996 1755
3. Y. Pan, A. Grindstaff, D. Cassada Bilateral reduction mammoplasty in a patient treated with calcium channel blocker and Cyclosporin after renal transplantation a case report Transplantation 63 1997 1032
4. G.V. Mazariegos, A.A. Salzedas, A. Jain Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients Paediatr Drugs 3 2001 661
5. T. Satoh, H. Munakata, K. Fujita Studies on the interactions between drug and estrogen II on the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17 Biol Pharm Bull 26 2003 695